Loading...
•
Jun 30, 2023
Tenet Healthcare Q2 2023 Earnings Report
Tenet Healthcare's financial performance for Q2 2023 was reported, featuring increase in net income and adjusted EPS.
Key Takeaways
Tenet Healthcare reported a net income of $123 million, or $1.15 per diluted share, and an adjusted diluted earnings per share of $1.44 for Q2 2023. The company's ambulatory care segment saw a 16.4% increase in Adjusted EBITDA, and same-facility system-wide surgical cases increased by 6.6%.
Net income from continuing operations available to common shareholders was $123 million, or $1.15 per diluted share.
Adjusted diluted earnings per share from continuing operations was $1.44.
Consolidated Adjusted EBITDA was $843 million, including $8 million of grant income.
Ambulatory Care Adjusted EBITDA increased 16.4% over second quarter 2022, excluding grant income.
Tenet Healthcare
Tenet Healthcare
Tenet Healthcare Revenue by Segment
Revenue by Segment
Ambulatory Care Revenue
CapyFin.comHospital Operations and Services Revenue
CapyFin.com Forward Guidance
Tenet Healthcare's Outlook for full year 2023 includes net operating revenues between $20.1 billion and $20.5 billion, and Adjusted EBITDA between $3.310 billion and $3.460 billion.
Positive Outlook
- Net operating revenues are expected to be in the range of $20,100 million to $20,500 million.
- Income from continuing operations available to Tenet common stockholders are expected to be in the range of $447 million to $582 million.
- Adjusted EBITDA is expected to be in the range of $3,310 million to $3,460 million.
- Diluted income per common share from continuing operations is expected to be $4.19 to $5.48.
- Adjusted diluted earnings per share from continuing operations is expected to be $5.18 to $6.03.
Revenue & Expenses
Visualization of income flow from segment revenue to net income